Jefferies has downgraded Teva Pharmaceuticals (NYSE: TEVA) to a Hold rating (from Buy) but raised the price target to $12 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE